243 related articles for article (PubMed ID: 37658995)
21. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
[TBL] [Abstract][Full Text] [Related]
22. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
[No Abstract] [Full Text] [Related]
23. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
Onizuka H; Masui K; Komori T
Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
[TBL] [Abstract][Full Text] [Related]
24. [Contributions and limitations of FISH analysis for the diagnosis of central nervous system tumors according to the 2021 WHO classification: Feedback from Sainte-Anne Hospital's Department of Neuropathology].
Tauziède-Espariat A; Tartar A; Mehdi L; Pucelle N; Lacombe J; Berthaud C; Brigot E; Massé J; Métais A; Benzakoun J; Hasty L; Chrétien F; Varlet P
Ann Pathol; 2023 Nov; 43(6):443-451. PubMed ID: 37385935
[TBL] [Abstract][Full Text] [Related]
25. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
26. WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification.
Tran S; Bielle F
Curr Opin Oncol; 2022 Nov; 34(6):670-675. PubMed ID: 36093875
[TBL] [Abstract][Full Text] [Related]
27. World Health Organization Classification of Tumors of the Central Nervous System 5
Mahajan S; Suri V; Sahu S; Sharma MC; Sarkar C
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S5-S13. PubMed ID: 35562129
[TBL] [Abstract][Full Text] [Related]
28. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
30. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
31. Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology.
Slocum CC; Park HJ; Baek I; Catalano J; Wells MT; Liechty B; Mathew S; Song W; Solomon JP; Pisapia DJ
Acta Neuropathol Commun; 2022 Nov; 10(1):167. PubMed ID: 36397144
[TBL] [Abstract][Full Text] [Related]
32. Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?
d'Amati A; Bargiacchi L; Rossi S; Carai A; Bertero L; Barresi V; Errico ME; Buccoliero AM; Asioli S; Marucci G; Del Baldo G; Mastronuzzi A; Miele E; D'Antonio F; Schiavello E; Biassoni V; Massimino M; Gessi M; Antonelli M; Gianno F
Front Mol Neurosci; 2024; 17():1268038. PubMed ID: 38544524
[TBL] [Abstract][Full Text] [Related]
33. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
[TBL] [Abstract][Full Text] [Related]
34. Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.
Sahm F; Brandner S; Bertero L; Capper D; French PJ; Figarella-Branger D; Giangaspero F; Haberler C; Hegi ME; Kristensen BW; Kurian KM; Preusser M; Tops BBJ; van den Bent M; Wick W; Reifenberger G; Wesseling P
Neuro Oncol; 2023 Oct; 25(10):1731-1749. PubMed ID: 37279174
[TBL] [Abstract][Full Text] [Related]
35. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
[TBL] [Abstract][Full Text] [Related]
36. [Selected biomarkers in the primary tumors of the central nervous system: short review].
Rychlý B; Grossmann P; Steňo A; Pataky F
Cesk Patol; 2012 Apr; 48(2):65-71. PubMed ID: 22716052
[TBL] [Abstract][Full Text] [Related]
37. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
Cotter JA; Judkins AR
Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
[TBL] [Abstract][Full Text] [Related]
38. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
Yoda RA; Cimino PJ
Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
[TBL] [Abstract][Full Text] [Related]
39. Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.
Sturm D; Capper D; Andreiuolo F; Gessi M; Kölsche C; Reinhardt A; Sievers P; Wefers AK; Ebrahimi A; Suwala AK; Gielen GH; Sill M; Schrimpf D; Stichel D; Hovestadt V; Daenekas B; Rode A; Hamelmann S; Previti C; Jäger N; Buchhalter I; Blattner-Johnson M; Jones BC; Warmuth-Metz M; Bison B; Grund K; Sutter C; Hirsch S; Dikow N; Hasselblatt M; Schüller U; Koch A; Gerber NU; White CL; Buntine MK; Kinross K; Algar EM; Hansford JR; Gottardo NG; Schuhmann MU; Thomale UW; Hernáiz Driever P; Gnekow A; Witt O; Müller HL; Calaminus G; Fleischhack G; Kordes U; Mynarek M; Rutkowski S; Frühwald MC; Kramm CM; von Deimling A; Pietsch T; Sahm F; Pfister SM; Jones DTW
Nat Med; 2023 Apr; 29(4):917-926. PubMed ID: 36928815
[TBL] [Abstract][Full Text] [Related]
40. Methylation-based algorithms for diagnosis: experience from neuro-oncology.
Pickles JC; Stone TJ; Jacques TS
J Pathol; 2020 Apr; 250(5):510-517. PubMed ID: 32057098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
